Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00874432 · ClinicalTrials.gov registry record · Phase 2
Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00874432 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 43 participants.
The verdict
NCT00874432, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
The goal of this proposal is to investigate the potential for ACE-inhibitors (ACE-I)(drugs primarily used to treat hypertension or congestive heart failure) to prevent or delay cardiovascular disease (CVD) in older adults with chronic kidney disease (CKD) by examining their impact on aortic stiffness in people with stage 3 CKD in a randomized, controlled study.
Interventions
- DRUG lisinopril
- DRUG angiotensin converting enzyme inhibitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00874432
The ClinicalTrials.gov registry entry for NCT00874432 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lisinopril is the first listed.
NCT00874432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00874432 about?
NCT00874432 is a clinical study titled "Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease". The goal of this proposal is to investigate the potential for ACE-inhibitors (ACE-I)(drugs primarily used to treat hypertension or congestive heart failure) to prevent or delay cardiovascular disease (CVD) in older adults with chronic kidney disease (CKD) by examining their impact on aortic stiffnes...
What is the current status of trial NCT00874432?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2009-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00874432?
The interventions under investigation include: lisinopril (DRUG), angiotensin converting enzyme inhibitor (DRUG).
Who is sponsoring clinical trial NCT00874432?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.